Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Saved in:
| Title: | Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib. |
|---|---|
| Authors: | Dagogo-Jack I; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Manoogian A; Partners Health Specialty Pharmacy, Boston, MA., Jessop N; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Georgantas NZ; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Fintelmann FJ; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Farahani A; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Digumarthy SR; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Price MC; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Folch EE; Harvard Medical School, Boston, MA.; Interventional Pulmonology, Massachusetts General Hospital, Boston, MA., Keyes CM; Harvard Medical School, Boston, MA.; Interventional Pulmonology, Massachusetts General Hospital, Boston, MA., Do A; Massachusetts General Hospital Cancer Center, Boston, MA., Peterson JL; Massachusetts General Hospital Cancer Center, Boston, MA., Mino-Kenudson M; Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Pitman M; Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Rivera M; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Nardi V; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Dias-Santagata D; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Le LP; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Iafrate AJ; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Heist RS; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Ritterhouse LR; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Lennerz JK; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA. |
| Source: | JCO oncology practice [JCO Oncol Pract] 2023 Sep; Vol. 19 (9), pp. 786-792. Date of Electronic Publication: 2023 Jul 12. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
